Shimizu Hisayo, Nakagawa Masataka, Todaka Nemuri, Imaizumi Keitaro, Kurosawa Yasunori, Maruyama Toshiaki, Okumura C J, Shibata Takashi, Tanaka Yosuke, Sato Yoshinori, Ono Yasuo, Akuta Teruo
Kyokuto Pharmaceutical Industrial Co. Ltd., 7-8, Nihonbashi Kobunacho, Chuo-ku, Tokyo, 103-0024, Japan.
Abwiz Bio, Inc., 9823 Pacific Heights BLVD, Suite J, San Diego, CA 92121, USA.
Protein Expr Purif. 2018 Jun;146:27-33. doi: 10.1016/j.pep.2018.01.011. Epub 2018 Jan 31.
Rabbit monoclonal antibodies (mAbs) have many advantages over mouse antibodies in biological research and diagnostics applications because they exhibit high affinity and specificity. However, the methods of recombinant rabbit mAb production have not been optimized to the same extent as techniques used to produce mouse and human mAbs. In this study, we sought to optimize the production of a recombinant rabbit mAb against human plexin domain containing protein 2 (PLXDC2), a known cell surface antigen, by culturing HEK293-6E cells transfected with antibody-encoding genes at two different temperatures and by purifying the end-product by three different chromatography methods. The quality and function of purified antibody preparations were checked by electrophoresis and western blot analysis. The secreted rabbit mAb produced by a combination of culturing at 32 °C, purification by ammonium sulfate fractionation, and diethylaminoethyl resin (DEAE) ion exchange chromatography was of high quality. In contrast, the antibody produced by the cells grown at 37 °C for 6 days after transfection and purified by Protein A/G affinity method was low quality. Hypothermic conditions during production reduced protein heterogeneity probably by favorably affecting the levels of glycosylation and aggregation. In particular, according to western blotting data, CIMmultus DEAE chromatography that utilizes monolithic columns not only excluded inferior charge variants resulting from nonspecific reactions but also yielded rabbit mAb that was of better quality than commercially available rabbit polyclonal antibodies. The combination of techniques suggested by us may be a general approach to enhance product quality of rabbit mAbs produced by transient expression systems.
在生物学研究和诊断应用中,兔单克隆抗体(mAbs)相对于小鼠抗体具有许多优势,因为它们表现出高亲和力和特异性。然而,重组兔单克隆抗体制备方法的优化程度尚未达到生产小鼠和人单克隆抗体所使用技术的同等水平。在本研究中,我们试图通过在两种不同温度下培养转染了抗体编码基因的HEK293-6E细胞,并通过三种不同的色谱方法纯化终产物,来优化针对人含丛状蛋白结构域蛋白2(PLXDC2,一种已知的细胞表面抗原)的重组兔单克隆抗体的生产。通过电泳和蛋白质印迹分析检查纯化抗体制剂的质量和功能。通过在32°C培养、硫酸铵分级分离和二乙氨基乙基树脂(DEAE)离子交换色谱法相结合产生的分泌型兔单克隆抗体质量很高。相比之下,转染后在37°C生长6天的细胞产生并通过蛋白A/G亲和法纯化的抗体质量较低。生产过程中的低温条件可能通过有利地影响糖基化和聚集水平来降低蛋白质异质性。特别是,根据蛋白质印迹数据,利用整体柱的CIMmultus DEAE色谱法不仅排除了非特异性反应产生的劣质电荷变体,而且产生了质量优于市售兔多克隆抗体的兔单克隆抗体。我们建议的技术组合可能是提高瞬时表达系统产生兔单克隆抗体产品质量的通用方法。